PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
published in: Journal of Radiation Research
date of publication: 2020-03-01
main subject: esophageal carcinoma, olaparib
Cites articles
There is nothing here
Article - wd:Q92903399